Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000073

Chief Medical Officer sold 7,000 shares at an average $86.28 ($603,938)

  • Chief Medical Officer acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goncalves Joana · Chief Medical Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-15 Exercise or conversion : show line 1 in the form 10b5-1 +3,500 $6.84 $23,940 36,218 D
2026-07-15 Exercise or conversion : show line 2 in the form 10b5-1 +3,500 $7.80 $27,300 39,718 D
2026-07-15 Sale : show line 3 in the form 10b5-1 −400 $84.37 $33,746 39,318 D
2026-07-15 Sale : show line 4 in the form 10b5-1 −2,497 $85.86 $214,385 36,821 D
2026-07-15 Sale : show line 5 in the form 10b5-1 −3,803 $86.68 $329,630 33,018 D
2026-07-15 Sale : show line 6 in the form 10b5-1 −300 $87.25 $26,176 32,718 D
Open-market sales · 7,000 sh · avg $86.28 · $603,938

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-07-15 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) −3,500 200,563 D
2026-07-15 Exercise or conversion : show line 8 in the form 10b5-1 Employee Warrant (right to buy) −3,500 171,992 D
Loading xslF345X06/form4.xml…